PVR INOX Limited Annual Secretarial Compliance Report for FY 2025-26

PVR INOX Limited has successfully completed its annual secretarial compliance review for the financial year 2025-26. Conducted by M/s DPV & Associates LLP, the review confirms that the company has adhered to all necessary corporate governance standards, statutory requirements, and board-level policies. The audit highlights the company’s commitment to transparent disclosure practices, effective maintenance of internal policies, and robust management of shareholder interests throughout the fiscal year.

Commitment to Corporate Governance

PVR INOX Limited has demonstrated a high level of transparency and adherence to statutory mandates for the fiscal year ended March 31, 2026. The comprehensive secretarial audit conducted by independent professionals confirms that the company met all requirements regarding corporate conduct, ensuring that its operational framework aligns with industry-leading governance practices.

Audit Highlights and Findings

The review encompassed a detailed evaluation of board performance, policy adoption, and documentation standards. Key findings include:

  • Policy Updation: All corporate policies were timely reviewed and updated with board approval.
  • Transparency: The company maintains a fully functional and transparent website, ensuring accurate information dissemination to stakeholders.
  • Performance Evaluation: The board, independent directors, and committees successfully conducted annual performance evaluations.
  • Related Party Transactions: All transactions were reviewed and approved by the Audit Committee, with no instances requiring retroactive rectification.

Operational Compliance

The report confirms that there were no actions taken against the company or its directors by market authorities during the review period. Furthermore, all disclosure requirements regarding material events and subsidiary management were handled in full compliance with mandated timelines. The audit serves as an independent validation of the company’s internal controls and its ongoing dedication to operational excellence and shareholder accountability.

Source: BSE

Previous Article

Akums Drugs and Pharmaceuticals Company and Subsidiary Receive Income Tax Assessment Orders